Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 Oct 28

PMID 37896892

Authors

Swetha Pinninti

Suresh Boppana

Affiliations

Soon will be listed here.

Abstract

Human Cytomegalovirus (HCMV) is a ubiquitous member of the Herpesviridae family, responsible for the most common congenital viral infection-congenital Cytomegalovirus (cCMV) infection. While a majority of HCMV infections in children and adults are asymptomatic, HCMV is well known to cause severe infections in the immunocompromised individual and maternal infections with variable long-term sequelae after maternal-fetal transmission with primary or nonprimary infections. HCMV seroprevalence and cCMV incidence vary by geographic area and demographic characteristics like race and socioeconomic status. While cCMV birth prevalence ranges from 0.2% to 6% in different parts of the world, it is influenced by regional HCMV seroprevalence rates. HCMV screening during pregnancy is not routinely offered due to lack of awareness, hurdles to accurate diagnosis, and lack of well-established effective treatment options during pregnancy. This review will focus on antiviral treatment options currently available for use during pregnancy and in the newborn period for the treatment of maternal and congenital HCMV infections.

Citing Articles

The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case.

Giardini V, Chiozzi R, Fernicola F, Casati M, Locatelli A, Ornaghi S Viruses. 2025; 17(2).

PMID: 40007022 PMC: 11860600. DOI: 10.3390/v17020267.

The Impact of Latent Cytomegalovirus Infection on Spontaneous Abortion History and Pregnancy Outcomes in Romanian Pregnant Women.

Mocanu A, Stoian D, Daescu A, Motofelea A, Ciohat I, Navolan D Microorganisms. 2024; 12(4).

PMID: 38674675 PMC: 11052013. DOI: 10.3390/microorganisms12040731.

Maternal and congenital human cytomegalovirus infection: laboratory testing for detection and diagnosis.

Leber A J Clin Microbiol. 2024; 62(4):e0031323.

PMID: 38391188 PMC: 11005381. DOI: 10.1128/jcm.00313-23.

References

Kimberlin D, Jester P, Sanchez P, Ahmed A, Arav-Boger R, Michaels M . Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015; 372(10):933-43. PMC: 4401811. DOI: 10.1056/NEJMoa1404599. View

Bernstein D, Munoz F, Callahan S, Rupp R, Wootton S, Edwards K . Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial. Vaccine. 2015; 34(3):313-9. PMC: 4701617. DOI: 10.1016/j.vaccine.2015.11.056. View

McCrary H, Sheng X, Greene T, Park A . Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir. Int J Pediatr Otorhinolaryngol. 2019; 118:124-127. PMC: 6363845. DOI: 10.1016/j.ijporl.2018.12.027. View

Perillaud-Dubois C, Letamendia E, Picone O, Bonnin A, Bouthry E, Letourneau A . Severe Symptomatic Congenital Cytomegalovirus (CMV) Infection Due to Maternal CMV Primary Infection After 20 Weeks of Gestation. Clin Infect Dis. 2019; 70(1):174-176. DOI: 10.1093/cid/ciz401. View

Trang J, Kidd L, Gruber W, Storch G, Demmler G, Jacobs R . Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther. 1993; 53(1):15-21. DOI: 10.1038/clpt.1993.4. View

Fowler K, McCollister F, Sabo D, Shoup A, Owen K, Woodruff J . A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening. Pediatrics. 2017; 139(2). PMC: 5260148. DOI: 10.1542/peds.2016-2128. View

Britt W . Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity. J Infect Dis. 2020; 221(Suppl 1):S1-S8. PMC: 7057782. DOI: 10.1093/infdis/jiz464. View

DAntonio F, Marinceu D, Prasad S, Khalil A . Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022; 61(4):436-444. DOI: 10.1002/uog.26136. View

Pass R, Zhang C, Evans A, Simpson T, Andrews W, Huang M . Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med. 2009; 360(12):1191-9. PMC: 2753425. DOI: 10.1056/NEJMoa0804749. View

10.

Lanzieri T, Caviness A, Blum P, Demmler-Harrison G . Progressive, Long-Term Hearing Loss in Congenital CMV Disease After Ganciclovir Therapy. J Pediatric Infect Dis Soc. 2021; 11(1):16-23. PMC: 9590555. DOI: 10.1093/jpids/piab095. View

11.

Craeghs L, Goderis J, Acke F, Keymeulen A, Smets K, Van Hoecke H . Congenital CMV-Associated Hearing Loss: Can Brain Imaging Predict Hearing Outcome?. Ear Hear. 2020; 42(2):373-380. DOI: 10.1097/AUD.0000000000000927. View

12.

Ahlfors K, Ivarsson S, Harris S . Secondary maternal cytomegalovirus infection--A significant cause of congenital disease. Pediatrics. 2001; 107(5):1227-8. DOI: 10.1542/peds.107.5.1227. View

13.

Ogawa H, Suzutani T, Baba Y, Koyano S, Nozawa N, Ishibashi K . Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis. 2007; 195(6):782-8. DOI: 10.1086/511981. View

14.

Ross S, Ahmed A, Palmer A, Michaels M, Sanchez P, Bernstein D . Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis. 2014; 210(9):1415-8. PMC: 4271051. DOI: 10.1093/infdis/jiu263. View

15.

Nigro G, La Torre R, Anceschi M, Mazzocco M, Cosmi E . Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am J Obstet Gynecol. 1999; 180(5):1222-6. DOI: 10.1016/s0002-9378(99)70620-4. View

16.

Chatzakis C, Ville Y, Makrydimas G, Dinas K, Zavlanos A, Sotiriadis A . Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol. 2020; 223(6):870-883.e11. DOI: 10.1016/j.ajog.2020.05.038. View

17.

Dreher A, Arora N, Fowler K, Novak Z, Britt W, Boppana S . Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014; 164(4):855-9. PMC: 3982912. DOI: 10.1016/j.jpeds.2013.12.007. View

18.

Lucignani G, Rossi Espagnet M, Napolitano A, Talamanca L, Calo Carducci F, Auriti C . A new MRI severity score to predict long-term adverse neurologic outcomes in children with congenital Cytomegalovirus infection. J Matern Fetal Neonatal Med. 2019; 34(6):859-866. DOI: 10.1080/14767058.2019.1620725. View

19.

Fisher S, Miller E, Yee L, Grobman W, Premkumar A . Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis. Am J Obstet Gynecol MFM. 2022; 4(5):100676. DOI: 10.1016/j.ajogmf.2022.100676. View

20.

Kagan K, Enders M, Schampera M, Baeumel E, Hoopmann M, Geipel A . Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration. Ultrasound Obstet Gynecol. 2018; 53(3):383-389. DOI: 10.1002/uog.19164. View